Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease
Status:
Completed
Trial end date:
2017-05-18
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of azithromycin, rifabutin and ethambutol given three
times weekly in the treatment of lung infection with M. avium complex(MAC)
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center at Tyler